logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

The Rise And Fall Of The Age Of Psychopharmacology Edward Shorter

  • SKU: BELL-40665934
The Rise And Fall Of The Age Of Psychopharmacology Edward Shorter
$ 31.00 $ 45.00 (-31%)

4.7

76 reviews

The Rise And Fall Of The Age Of Psychopharmacology Edward Shorter instant download after payment.

Publisher: Oxford University Press
File Extension: PDF
File size: 2.67 MB
Pages: 448
Author: Edward Shorter
ISBN: 9780197574430, 9780197574454, 9782021016420, 2021016420, 0197574432, 0197574459, 2021016419
Language: English
Year: 2021

Product desciption

The Rise And Fall Of The Age Of Psychopharmacology Edward Shorter by Edward Shorter 9780197574430, 9780197574454, 9782021016420, 2021016420, 0197574432, 0197574459, 2021016419 instant download after payment.

The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind. But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients. Behind this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.

Related Products